Black Swan Graphene expands UK output above 140 tonnes as it closes in on industrial-scale manufacturing

Black Swan Graphene said on April 11, 2026, that it has raised annual graphene nanoplatelet capacity at its Consett, England facility to more than 140 tonnes after commissioning a large-scale production system. The update marks the company’s fourth and largest scale-up so far and gives it a materially bigger manufacturing base as graphene demand remains concentrated in applications that need consistent, high-volume supply.

Consett plant passes a new production threshold

The company said the upgraded line is now operating at more than 140 tonnes a year, up from about 40 tonnes before the expansion. Black Swan described the change as a transition toward industrial-scale manufacturing rather than a pilot or demonstration program, a distinction that matters in a materials market where many graphene producers still operate at small volumes.

The expansion was completed at Black Swan’s existing UK site, which already had the utilities and production infrastructure needed for a larger system. That lowers one common scale-up barrier: building around a new plant footprint instead of adding capacity inside an established operation.

Graphene supply is still the bottleneck for downstream adoption

For buyers in polymers, composites and other industrial sectors, the main constraint is often not whether graphene performs in the lab, but whether suppliers can deliver enough material at repeatable quality and a price that supports production use. Black Swan’s latest step is aimed at that problem, increasing the company’s ability to serve volume customers rather than only development partners.

The larger capacity also gives the company more room to support customer trials, product qualification and commercial rollouts without tying up a disproportionate share of output in small-batch runs. In graphene, that can be the difference between promising test data and a repeatable manufacturing supply chain.

Black Swan links the expansion to commercial packaging and mobility work

The company has said it is targeting high-volume markets such as concrete, polymers and packaging-related applications, where graphene nanoplatelets can be used to modify mechanical, thermal or barrier properties. A larger production line should help Black Swan respond to orders that require steadier supply commitments and tighter process control.

The scale-up also reflects a broader shift in the graphene sector: the technical challenge is moving from proving the material to producing it reliably at a meaningful industrial scale. Black Swan’s latest expansion does not eliminate that hurdle, but it does move the company further along the path from specialty material supplier to high-volume manufacturer.